Magnetic Patch for Vascular Ulcer Enzyme Removal
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for vascular ulcers, particularly those resulting from deep vein thrombosis, lack effective alternatives for addressing the enzymatic activity that contributes to their formation and persistence, such as excessive matrix metalloproteinases (MMPs), which hinder proper healing and tissue regeneration.
Innovation Solution
A medical device kit and method utilizing a linking material coupled with magnetic nanoparticles to attract and remove MMPs from the wound site by applying a magnetic field, where the linking material, often a chelating agent like EDTA, binds to metal ions complexed by MMPs, facilitating their extraction from the vascular ulcer.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments for vascular ulcers are used, then general wound care is provided, but they fail to effectively address excessive matrix metalloproteinases that contribute to ulcer formation and persistence
Solution Approach 1:
The patent introduces a linking material as an intermediary substance that specifically binds to matrix metalloproteinases. This linking material acts as a mediator between the magnetic nanoparticles and the target enzymes, enabling selective removal of MMPs while leaving other wound components unaffected. The linking material provides the adaptability needed to specifically address enzymatic activity that conventional treatments cannot target.
Solution Approach 2:
The patent extracts the harmful enzymatic activity from the wound environment by using magnetic nanoparticles functionalized with linking materials to bind and remove matrix metalloproteinases. This extraction principle directly addresses the excessive MMPs that contribute to ulcer formation, providing a targeted removal mechanism that conventional general wound care treatments lack.
2Reliability
If magnetic nanoparticles with linking material are applied to remove MMPs, then MMP levels are reduced and healing is promoted, but the device complexity increases
Solution Approach 1:
The patent employs composite materials by combining magnetic nanoparticles with linking materials that have affinity for matrix metalloproteinases. This composite structure integrates multiple functions into a single treatment agent: the magnetic properties enable external control and removal, while the linking material provides specific binding to target enzymes. The composite material approach achieves effective MMP removal without requiring complex separate systems for binding and removal.
Solution Approach 2:
The patent replaces complex biochemical methods for enzyme removal with a magnetic field-based mechanical system. Instead of using complex enzymatic inhibitors or surgical interventions, the treatment uses external magnetic fields to guide and remove the functionalized nanoparticles, simplifying the overall treatment approach while maintaining high effectiveness.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively reduces MMP levels in the wound, slowing or reversing tissue degeneration, promoting healing by decreasing the breakdown of collagen and other extracellular matrix proteins, thereby enhancing the recovery rate from vascular ulcers.
Implementation Method 1
A medical device kit and method utilizing a linking material coupled with magnetic nanoparticles to attract and remove MMPs from the wound site by applying a magnetic field
Implementation Method 2
the linking material, often a chelating agent like EDTA, binds to metal ions complexed by MMPs
Data Source
AI summary
A patch for treating vascular ulcers caused by excessive enzymatic activity may include a substrate configured to span a vascular ulcer as well as a linking material that is disposed relative to the substrate and has an affinity for an enzyme involved in causing the vascular ulcer. A magnetic material may be coupled to the linking material. In some cases, the enzymes involved in causing the vascular ulcer may become coupled to the linking material and thus become coupled to the magnetic material so that that the enzymes can be removed by applying a magnetic field in the proximity of the vascular ulcer. The enzymes may include matrix metalloproteinases.